[1]
M. R. Lima, L. A. B. G. Farias, M. F. da Ponte, and L. E. T. de A. Furtado, “Self-Limited Cytomegalovirus Infection During Natalizumab Treatment for Multiple Sclerosis”, EJCRIM, vol. 6, no. 2, Feb. 2019.